TAM
FATE icon

Tocqueville Asset Management’s Fate Therapeutics FATE Stock Holding History

Tocqueville Asset Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,000
Closed -$68K – 808
2017
Q1 		$68K Hold
15,000
– – ﹤0.01% 786
2016
Q4 		$38K Sell
15,000
-7,000
-32% -$18.7K ﹤0.01% 792
2016
Q3 		$69K Hold
22,000
– – ﹤0.01% 809
2016
Q2 		$37K Hold
22,000
– – ﹤0.01% 829
2016
Q1 		$40K Sell
22,000
-78,000
-78% -$161K ﹤0.01% 846
2015
Q4 		$337K Sell
100,000
-4,000
-4% -$16.8K ﹤0.01% 746
2015
Q3 		$554K Buy
104,000
+4,000
+4% +$27.3K 0.01% 675
2015
Q2 		$647K Buy
+100,000
New +$598K 0.01% 654

Other funds holding FATE

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return